Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
17 studies found for:    "Epidermolysis Bullosa Dystrophica" OR "dystrophic epidermolysis bullosa"
Show Display Options
Download search resultsDownload the search results for:
"Epidermolysis Bullosa Dystrophica" OR "dystrophic epidermolysis bullosa" (17 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Withdrawn Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Intervention:
2 Terminated Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer
Condition: Epidermolysis Bullosa Dystrophica
Intervention:
3 Recruiting Characteristics of Patients With Dystrophic Epidermolysis Bullosa
Condition: Epidermolysis Bullosa Dystrophica
Intervention:
4 Completed Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
Condition: Epidermolysis Bullosa Dystrophica
Intervention:
5 Recruiting Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa
Conditions: Epidermolysis Bullosa Dystrophica;   Epidermolysis Bullosa
Intervention: Genetic: LZRSE-Col7A1 Engineered Autologous Epidermal Sheets (LEAES)
6 Withdrawn A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Interventions: Biological: HP802-247;   Other: Placebo
7 Recruiting Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Intervention: Drug: Granulocyte Colony Stimulating Factor (GCSF)
8 Terminated
Has Results
Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)
Conditions: Epidermolysis Bullosa, Junctional;   Epidermolysis Bullosa Dystrophica
Interventions: Device: Apligraf;   Other: Standard dressing regimen
9 Completed Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care
Conditions: Epidermolysis Bullosa Dystrophica;   Epidermolysis Bullosa
Interventions: Device: Helicoll;   Device: Standard of Care Dressings
10 Completed Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)
Condition: Epidermolysis Bullosa Dystrophica
Interventions: Drug: Polyphenon E before Placebo;   Drug: placebo before treatment
11 Recruiting Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Condition: Recessive Dystrophic Epidermolysis Bullosa
Interventions: Other: Blood collection;   Other: Skin biopsies
12 Recruiting Short Term Observational Study in DEB Patients
Condition: Dystrophic Epidermolysis Bullosa
Intervention:
13 Not yet recruiting Pilot Study Evaluating the Efficiency and the Tolerance of the PDT in the Treatment of Epidermal Dysplasia for Patients Affected by Hereditary DEB
Condition: Dystrophic Epidermolysis Bullosa
Intervention: Procedure: Photodynamic therapy (PDT)
14 Not yet recruiting A Comparative Study of the Healing of Chronic Ulcers of Recessive Epidermolysis Bullosa : Dressing vs Amniotic Membrane
Conditions: Epidermolysis Bullosa Dystrophica, Recessive;   Ulcer
Intervention: Device: Amniotic Membrane
15 Unknown  Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Condition: Epidermolysis Bullosa
Intervention: Drug: Reduced Intensity Transplant conditioning
16 Unknown  Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: isotretinoin
17 Terminated
Has Results
Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Procedure: hematopoietic bone marrow transplantation

Indicates status has not been verified in more than two years